Department of Otorhinolaryngology-Head and Neck Surgery, Inha University College of Medicine, Incheon, Korea.
Otolaryngol Head Neck Surg. 2010 Jun;142(6):832-7. doi: 10.1016/j.otohns.2010.01.024.
The aim of this study was to evaluate the outcome and predictive factors for salvage treatment of isolated neck recurrence after primary curative surgery for head and neck squamous cell carcinoma (HNSCC).
Case series with chart review.
Head and neck cancer clinic in a tertiary care university hospital.
A retrospective study was conducted with 236 patients who developed a recurrence after primary curative surgery with or without radiotherapy for HNSCC.
Isolated neck recurrence developed in 61 (26%) patients. Salvage treatment was offered to 49 patients, and the overall salvage rate was 33 percent (20 of 61). The salvage rate for the surgical salvage group was 46 percent (16 of 35) and 28 percent (4 of 14) for the nonsurgical salvage group (chemoradiation) (P = 0.14). The three-year overall survival rate was 36 percent for patients with surgical salvage and 12 percent for patients with nonsurgical salvage (P = 0.101). There were no survivors of the supportive care group (0 of 12). Univariate analysis of individuals with isolated neck recurrence showed that patients who had previous treatment with surgery alone, a disease-free time longer than one year, previous pathologic N- status, recurrence in the undissected neck, or recurrent N1 had significantly improved salvage time (P < 0.05). However, in multivariate analysis, the factors previous treatment with surgery alone and recurrent N1 submitted to the salvage treatment were independent predictors of a successful salvage of isolated neck recurrence.
Our results suggest that the ideal candidates for salvage neck treatment include those patients with recurrent N1 disease and those whose previous treatment was surgery only.
本研究旨在评估头颈部鳞状细胞癌(HNSCC)根治性手术后单纯颈部复发的治疗结果和预测因素。
病例系列回顾性研究。
三级护理大学医院头颈部癌症诊所。
对 236 例接受根治性手术(伴或不伴放疗)治疗 HNSCC 后出现复发的患者进行了回顾性研究。
61 例(26%)患者出现孤立性颈部复发。49 例患者接受了挽救性治疗,总体挽救率为 33%(20/61)。手术挽救组的挽救率为 46%(16/35),非手术挽救组(放化疗)为 28%(4/14)(P=0.14)。手术挽救组患者的 3 年总生存率为 36%,非手术挽救组患者的 3 年总生存率为 12%(P=0.101)。接受支持性治疗的 12 例患者均无存活者。对孤立性颈部复发患者的单因素分析显示,既往单纯手术治疗、无疾病间期>1 年、既往病理 N 状态、未切除颈部复发或复发性 N1 的患者,挽救时间显著延长(P<0.05)。然而,多因素分析显示,既往单纯手术治疗和接受挽救性治疗的复发性 N1 是孤立性颈部复发成功挽救的独立预测因素。
我们的结果表明,接受挽救性颈部治疗的理想患者包括复发性 N1 疾病患者和既往单纯手术治疗的患者。